| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |